Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01549613 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections
A Phase 4 study of Cellulitis and Skin Infections, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 4
- Development phase
- 104
- Enrollment target
- 1
- Study location
NCT01549613: Completed Phase 4 study of Cellulitis and Skin Infections, sponsored by University of Cincinnati.
NCT01549613 is a Phase 4 study of Cellulitis and Skin Infections that has completed, run by University of Cincinnati. The registered enrollment target is 104 participants, below the 561-participant average among 11 other Cellulitis trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01549613, a Phase 4 study of Cellulitis and Skin Infections, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 104 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, randomized clinical trial comparing daptomycin to vancomycin in the Emergency Department (ED) treatment of complicated skin and skin structure infection in the Rapid Diagnosis and Treatment Center (RDTC). In brief, a convenience sample of patients who are admitted to the RDTC cellulitis protocol in the ED will be randomized to either vancomycin, which is currently an accepted care standard in the RDTC cellulitis protocol, or daptomycin, which is the experimental treatment in this study. The primary hypothesis is that daptomycin treatment is as efficacious as standard therapy in the treatment of ED cellulitis.
Primary Outcome
RDTC cellulitis protocol discharge criteria
Conditions Studied
Interventions
- DRUG Vancomycin
- DRUG Daptomycin
Study Locations (1)
Ohio
- University of Cincinnati, Dept. of Emergency Medicine - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-07 |
| Phase | Phase 4 |
What the finished NCT01549613 record still lists
NCT01549613 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 561-participant average among 11 other Cellulitis trials with a reported enrollment target (81% lower).
The record links to 2 conditions, with Cellulitis appearing as the primary indexed condition, and to 2 interventions - of which Vancomycin is the first listed.
NCT01549613 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01549613 about?
NCT01549613 is a clinical study titled "Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections". This is a prospective, randomized clinical trial comparing daptomycin to vancomycin in the Emergency Department (ED) treatment of complicated skin and skin structure infection in the Rapid Diagnosis and Treatment Center (RDTC). In brief, a convenience sample of patients who are admitted to the RDTC ...
What is the current status of trial NCT01549613?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 104 participants. The study started on 2012-05. Estimated completion is 2013-07.
What conditions does trial NCT01549613 study?
This clinical trial studies the following conditions: Cellulitis, Skin Infections.
What interventions are being tested in trial NCT01549613?
The interventions under investigation include: Vancomycin (DRUG), Daptomycin (DRUG).
Who is sponsoring clinical trial NCT01549613?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01549613 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cellulitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01549613's enrollment target sits among peer trials
104 8th of 11 higher than 4 of 11 other Cellulitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cellulitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas
COMPLETED · Phase 4
-
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
ACTIVE NOT RECRUITING · NA
-
Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage
COMPLETED · Phase 2
-
Utility of Thermal Imaging in Diagnosis of Cellulitis for Lower Extremity Complaints in the Emergency Department
COMPLETED
-
Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care
COMPLETED · NA
-
Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia